Authoratory™
 
This website is accredited by Health On the Net Foundation. Click to verify.
Bookmark and Share

4P Ken Gillman

 

Summary for 2004 [at-glance overview of P Ken Gillman work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author P Ken Gillman. According to available data, in 2004 P Ken Gillman published at least 4 articles. There was no collaboration between P Ken Gillman and other authors this year. There is no information about the funding or the grants awarded to support this work.

P Ken Gillman is a key opinion leader in the specific area of Serotonin Syndrome. This author's rank is 1 when compared to all other authors using the same keyword. Analysis of the article abstracts and the titles suggests that P Ken Gillman professional interests are focused around "psychiatry 114-115 making", "world" and "co-administration linezolid venlafaxine". These might also be referred to as "serotonin toxicity", "biol psychiatry" or "world". Statistical analysis shows that P Ken Gillman's writing is likely to contains terms "serotonin", "comment", "toxicity", "world", "et" and "antidepressant".

Unfortunately, there is no affiliation information in P Ken Gillman articles. Sadly, no email addresses were found for any of the affiliations.

ENFRESRUAccurate information, makes sense to meInaccurate information, needs improvementmake correctionleave commentask question

Images [images we found on the Internet for P Ken Gillman]

    loading...

    Do you know P Ken Gillman who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to P Ken Gillman]

Year 2004 Charts [P Ken Gillman frequent coauthors and the most common unique vocabulary terms for the selected year]

  • P Ken Gillman - Coauthors & Social Network in 2004P Ken Gillman - Unique Vocabulary, Keywords and Interests in 2004

Historical Performance Charts [graphical overview of P Ken Gillman publication and funding history for the range of years]

  • P Ken Gillman - Publications and Funding History in 2004

P Ken Gillman Coauthors (0) [all coauthors with the number of joint publications]

no coauthors
 

Other [context-specific ads]

Key Opinion Leader In [P Ken Gillman is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

  • 1Serotonin Syndrome

Keywords (17) [keywords assigned to P Ken Gillman articles by PubMed, the leading number and the color conveys importance]

  • 4Humans | 3Serotonin Syndrome | 2Serotonin Uptake Inhibitors | 2Serotonin | 1Drug Interactions | 1Risk Factors | 1Drug Synergism | 1Cyclohexanols | 1Oxazolidinones | 1Fluoxetine | 1Acetamides | 1Benzodiazepines | 1Depression | 1Anti-Bacterial Agents | 1Mianserin | 1Antidepressive Agents, Tricyclic | 1Synaptic Transmission

P Ken Gillman Unique Vocabulary (79) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; P Ken Gillman might be a good expert witness on these terms]

  • 3serotonin | 2comment | 2toxicity | 1world | 1et | 1antidepressant | 1making | 1chopra | 1syndrome | 1due | 1action | 1114-115 | 1co-administration | 1al | 1dual | 1venlafaxine | 1sense | 1mirtazapine | 1linezolid | 1psychiatry | 1spectrum | 1concept | 1biol | 1reports
  • 2serotonin toxicity | 1biol psychiatry | 1world | 1mirtazapine dual | 1comment chopra | 1comment serotonin | 1due co-administration | 1chopra et | 1mirtazapine | 1spectrum | 1world biol | 1spectrum concept | 1action antidepressant | 1linezolid venlafaxine | 1syndrome due | 1co-administration linezolid | 1dual action | 1psychiatry 114-115 | 1serotonin syndrome | 1concept serotonin | 1114-115 making | 1sense serotonin | 1reports comment | 1et al | 1making sense | 1toxicity reports | 1antidepressant comment
  • 1psychiatry 114-115 making | 1world | 1co-administration linezolid venlafaxine | 1sense serotonin toxicity | 1mirtazapine dual | 1concept serotonin toxicity | 1due co-administration linezolid | 1comment serotonin syndrome | 1reports comment chopra | 1action antidepressant comment | 1biol psychiatry 114-115 | 1mirtazapine | 1serotonin toxicity reports | 1114-115 making sense | 1spectrum | 1world biol | 1spectrum concept | 1spectrum concept serotonin | 1dual action antidepressant | 1toxicity reports comment | 1making sense serotonin | 1mirtazapine dual action | 1chopra et al | 1comment chopra et | 1serotonin syndrome due | 1world biol psychiatry | 1antidepressant comment serotonin | 1syndrome due co-administration

Reader's Comments (2) [comments posted by readers of P Ken Gillman profile]

Reader Correction: [Gillman, P Ken] in 2009 [posted by Ken Gillman on Sun, 21 Feb 2010 13:52:15 GMT]

[1] Gillman PK. Mechanisms, management and measurement in atropine induced hyperthermia. Anaesth Intensive Care. 2009;37:322-3.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19400503
[2] Gillman PK. Is there sufficient evidence to suggest cyclobenzaprine might be implicated in causing serotonin toxicity? Am J Emerg Med. 2009;27:509-10.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19555629
[3] Gillman PK. Fentanyl and serotonin toxicity. Br J Anaesth. 2009:http://bja.oxfordjournals.org/cgi/eletters/95/4/434#4135.


[4] Gillman PK. Lessons continue: serotonin toxicity. Consult Pharm. 2009;24:398-9.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19694109
[5] Gillman PK. Triptans, Serotonin Agonists, and Serotonin Syndrome (Serotonin Toxicity): A Review. Headache. 2009;50:264-72.
10.1111/j.1526-4610.2009.01575.x. PMID: 19925619.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19925619
[6] Gillman PK. In response to Morris et al.'s "Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine". J Med Toxicol. 2009;5:259.
10.1007/BF03178278.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20012252
[7] Gillman PK. Myths about MAOIs uncritically perpetuated. Aust N Z J Psychiatry. 2009;43:[in press].


[8] Gillman PK. In Reference to Parathyroid Surgery and Methylene Blue: a Review with Guidelines for Safe Intraoperative Use. Laryngoscope. 2010;120:436-7.
PMID: 19950381.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19950381
[9] Gillman PK. Combining antidepressants: Understanding Drug Interactions is the Sine Qua Non. Adv Psychiatr Treat. 2010;16:76-8.
10.1192/apt.16.1.76.

[10] Gillman PK. More on Mrs Murphy’s beans: or ‘do us a fava’. J Clinic Psychopharmacol. 2010;30:[In Press].


[11] Schwiebert C, Irving C, Gillman PK. Small doses of methylene blue, previously considered safe, can precipitate serotonin toxicity. Anaesthesia. 2009;64:924-.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19604213
[12] Stanford SC, Stanford BJ, Gillman PK. Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium. J Psychopharmacol (Oxf). 2009 May 7:10.1177/0269881109105450.
10.1177/0269881109105450. 19423610.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19423610

Reader Comment: [Gillman, P Ken] in 2009 [posted by Ken Gillman on Thu, 11 Feb 2010 09:55:19 GMT]

My pubs 2009/10
[1] Gillman PK. Meperidine (pethidine) and toxicity. Br J Anaesth. 2010
http://bja.oxfordjournals.org:80/cgi/eletters/103/3/369#5444
[2] Gillman PK. More on Mrs Murphy’s beans: or ‘do us a fava’. J Clinic Psychopharmacol. 2010;30:[In Press].


[3] Gillman PK. Combining antidepressants: Understanding Drug Interactions is the Sine Qua Non. Adv Psychiatr Treat. 2010;16:76-8.
10.1192/apt.16.1.76.

[4] Gillman PK. In Reference to Parathyroid Surgery and Methylene Blue: a Review with Guidelines for Safe Intraoperative Use. Laryngoscope. 2010;120:436-7.
PMID: 19950381.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19950381
[5] Gillman PK. CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity. J Psychopharmacol (Oxf). 201010.1177/0269881109359098.
http://jop.sagepub.com/cgi/doi/10.1177/0269881109359098
[6] Stanford SC, Stanford BJ, Gillman PK. Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium. J Psychopharmacol (Oxf). 2009 May 7:10.1177/0269881109105450.
10.1177/0269881109105450. 19423610.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19423610
[7] Schwiebert C, Irving C, Gillman PK. Small doses of methylene blue, previously considered safe, can precipitate serotonin toxicity. Anaesthesia. 2009;64:924-.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19604213
[8] Gillman PK. Monoamine Oxidase Inhibitors, Dietary Tyramine and Drug Interactions. 2009:[accessed Dec 2009].

http://psychotropical.com/pdfs/maois_diet_full.pdf
[9] Gillman PK. Myths about MAOIs uncritically perpetuated. Aust N Z J Psychiatry. 2009;43:[in press].


[10] Gillman PK. The nature of hyperthermia in neuroleptic malignant syndrome and the use of bromocriptine. J Med Toxicol. 2009:[in press].


[11] Gillman PK. Triptans, Serotonin Agonists, and Serotonin Syndrome (Serotonin Toxicity): A Review. Headache. 2010;50:264-72.
10.1111/j.1526-4610.2009.01575.x. PMID: 19925619.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19925619
[12] Gillman PK. Lessons continue: serotonin toxicity. Consult Pharm. 2009;24:398-9.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19694109
[13] Gillman PK. Fentanyl and serotonin toxicity. Br J Anaesth. 2009:http://bja.oxfordjournals.org/cgi/eletters/95/4/434#4135.


[14] Gillman PK. Is there sufficient evidence to suggest cyclobenzaprine might be implicated in causing serotonin toxicity? Am J Emerg Med. 2009;27:509-10.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19555629
[15] Gillman PK. Mechanisms, management and measurement in atropine induced hyperthermia. Anaesth Intensive Care. 2009;37:322-3.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19400503

Funding (0) [selected NIH grants to P Ken Gillman and the award amounts for recent years]

  • award information is not available

P Ken Gillman Articles (4) [selected PubMed articles for the year 2004 with the links to a full text at PubMed]

  • Comment on: Serotonin syndrome due to co-administration of linezolid and venlafaxine. (2004) >>

    4Gillman, P Ken.

  • Making sense of serotonin toxicity reports, a comment on Chopra et Al. (World J Biol Psychiatry 2004, 5: 114-115). (2004) >>

    4Gillman, P Ken.

  • The spectrum concept of serotonin toxicity. (2004) >>

    4Gillman, P Ken.

  • Mirtazapine: not a dual action antidepressant? (2004) >>

    4Gillman, P Ken.

Science Trivia (2) [Interactive math & science trivia questions]